Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ADM Diagnostics
Northbrook, Illinois, USA
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
CorInsights MRI, an FDA 510(k) cleared product, provides advanced quantification/reporting of brain MRI for early and differential diagnosis of dementias and is used in clinical trials; the company’s platform is validated on tens of thousands of PET and MRI scans, supports both clinical and research applications, and is backed by NIH grants and key academic/professional collaborations[2][3][6].
- Therapeutic areas
- Neurology
- Modalities
- DeviceSoftwareImaging biomarkerArtificial intelligenceMachine learningCRO services
- Industry
- Medical Imaging
02
Partnerships
Alzheimer’s Drug Discovery FoundationMajor academic medical centersImaging Biomarkers group of Critical Path for Parkinson’s Consortium
Beyond the preview
Go deeper on ADM Diagnostics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ADM Diagnostics.